Search

everythinglearnresearchcommunity

for

Search:↓

The AndroCoV Clinical Scoring is a quick, accurate, and free tool for diagnosing COVID-19.

Trichoscopy is useful for diagnosing and monitoring hair and scalp conditions over time.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Ketoconazole increases finasteride's effectiveness and lifespan in the body.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Finasteride does not prevent bladder cancer.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Older adults still engage in sexual activities but face challenges like health issues and lack of professional support, highlighting the need for better healthcare provider education and research on sexual fulfillment in old age.

PRP treatment improves hair density and diameter in women with androgenetic alopecia.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Decorin helps keep hair follicle stem cells and may prevent age-related hair loss.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Dermoscopy is becoming essential for diagnosing skin conditions and is expected to be a standard tool for dermatologists.

Trichoscopy effectively diagnoses early female hair loss, but may need scalp biopsy for confirmation.

Finasteride doesn't affect oral testosterone undecanoate, and high DHT levels may cause acne, prostate issues, and hair loss.

Possible link between androgens and COVID-19 severity; more research needed.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

Finasteride affects SRD5A2 gene pattern, possibly causing lasting side effects.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Rice Bran Supercritical CO2 Extract significantly increased hair density and diameter in male alopecia patients without any side effects.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

Laser treatment effectively increases hair density and thickness in androgenic alopecia.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Finasteride microspheres help reduce hair loss for up to eight weeks with fewer side effects.